Navigation Links
Gene Tests Match Up Lung Tumors, Best Treatment
Date:10/3/2007

haps be treated with pemetrexed first."

The findings have formed the basis of a clinical trial -- the first of its kind in lung cancer -- currently being conducted at Duke University.

"These are not experimental drugs; we know they work. It's just a matter of giving each patient the right one on the first try," Potti said.

More information

The American Medical Association has more about lung cancer.



-- Robert Preidt



SOURCE: Duke University, news release, Sept. 28, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. IMA wants members not to do sex determination tests during pregnancy
2. Doctors advice early anemia tests
3. Early diagnosis for autism from blood tests may be possible
4. FDA approves Phase 0 trial which tests experimental drugs on humans
5. Genetic tests for cancer
6. Space research leads to needle-free blood tests
7. The Effectiveness Of Screening Tests Questioned
8. Blood Tests Can Help Detect Osteoporosis Early In Life
9. Easier Tests To Detect Tuberculosis
10. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
11. Skin tests confirms cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... , ... Transfinder, a software company based in Schenectady, N.Y., achieved record revenue ... for the first six months ended June 30, 2015 compared with the same period ... year’s record-revenue mark of $10.4 million. , “We know what our customers need and ...
(Date:7/31/2015)... ... 2015 , ... The Mount Sinai Health System will work with Columbia Care ... related, experimental treatments. The collaboration moves into the next phase with the recent decision ... five state licenses to produce and dispense medical marijuana. , Mount Sinai and ...
(Date:7/31/2015)... Falls Church, VA (PRWEB) , ... July 31, ... ... the Way, Oct. 20-21, 2015 – Washington, DC, http://www.fdanews.com/importexportprogram , Having ... But it doesn’t have to. , Instead of risking containment — or even ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Patients with higher ... to a study published today in Nature Communications and led by researchers from the ... suggests that variations in the gene RTN1 led to greater production of the related ...
(Date:7/31/2015)... ... ... Down is a reputable source of authentic USA vs. Australia tickets at Ford ... National Team in conjunction with their Victory Tour to celebrate winning the 2015 Women's World ... team was awarded the Golden Ball as the best player of the 2015 Women's World ...
Breaking Medicine News(10 mins):Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... coverage and access to health care , , FRIDAY, Jan. ... insurance and no regular source of health care are the ... University of Michigan C.S. Mott Children,s Hospital report. , The ... safeguard the health of vulnerable children, said the researchers, who ...
... Global Telemedicine Inc., supplies medical peripherals to the successful installations of ... advancing telemedicine program , ... N. Chelmsford, MA (PRWEB) ... Telemedicine has worked closely with Texas Tech University Health ...
... Jan. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc. (NYSE ... Chinese medicine ("TCM") based in Chengdu, China,today announced ... of shares,under its previously announced stock repurchase program. ... reducing the number of outstanding shares of its,common ...
... BOSTON, Jan. 30 Neurosilicon,s novel Photoconductive Stimulation Device ... Hung and Colicos titled, Astrocytic Ca2+ Waves Guide CNS ... article appearing in the November 2008 issue of The ... role of neuronal activity in mediating axonal guidance. It ...
... IDEXX Laboratories, Inc. (Nasdaq: IDXX ), ... 2008 were $243.3 million compared to $245.0 million for ... is reported growth adjusted to eliminate the effect of ... businesses acquired, divested or discontinued since October 1, 2007, ...
... ("QLT") (NASDAQ: QLTI ; TSX: QLT) announced the ... "Offer"), which expired at 5:00 p.m. (Eastern time) on January ... 20,000,000 of its common shares (the "Shares") at a price ... million. The purchased Shares represent approximately 26.8% of the Shares ...
Cached Medicine News:Health News:Medical Needs of 6.2 Million U.S. Kids Go Unmet 2Health News:Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas 2Health News:Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas 3Health News:Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program 2Health News:Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program 3Health News:Novel Photoconductive Cellular Depolarization Technology Reveals Insight Into Neuronal Growth, Guidance, and Regeneration 2Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 2Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 3Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 4Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 5Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 6Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 7Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 8Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 9Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 10Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 11Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 12Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 13Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 14Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 15Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 16Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 17Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 18Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 19Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 20Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 21Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 22Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 23Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 24Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 25Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 26Health News:QLT announces final results of tender offer 2
(Date:7/30/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the second quarter ending June 30, 2015. ... organization.  We are excited to be near the completion ... conducted with topline results expected in the fourth quarter," ... Therapeutics, Inc. "Translarna is now commercially available in 12 ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... 30, 2015 Eisai Inc. announced today that ... United States , European Union and ... respectively) for eribulin, for the treatment of patients with ... chemotherapy for advanced or metastatic disease. ... pivotal global Phase 3 clinical trial (Study 309), which ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... SUNNYVALE, Calif., Oct. 24, 2011 Accuray Incorporated (Nasdaq: ... that it will report results for its first quarter of ... 8, 2011 after the market closes. A conference ... fiscal year 2012 will begin at 2:00 p.m. PST/5:00 p.m. ...
... Awarepoint Corporation , the leading provider of ... the hiring of four senior management executives to support ... solutions in hospitals and clinics. Merrie Wallace, R.N., B.S.N., ... solutions, reporting to Awarepoint CEO Jay Deady. Chris Cosgrove ...
Cached Medicine Technology:Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012 2Awarepoint Expands Senior Management Team 2Awarepoint Expands Senior Management Team 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: